market

Corrected: Abbott’s diet drug study renews calls for U.S. ban (Reuters)

Reuters – A study funded by Abbott Laboratories offered more detailed evidence that its weight-loss drug Meridia increases heart risks, prompting renewed calls by consumer advocates and others to pull the drug from the market.

Original post: 
Corrected: Abbott’s diet drug study renews calls for U.S. ban
(Reuters)

market

Too little sleep bad for teenagers’ diets: study (Reuters)

Reuters – Teenagers who sleep less than eight hours a night on weeknights eat more fatty foods and snacks than those who get more than eight hours of sleep a night, U.S. researchers said on Wednesday.

See more here:
Too little sleep bad for teenagers’ diets: study
(Reuters)

market

Gene testing could have saved weight-loss drug (Reuters)

Reuters – Genetic testing might have helped identify people who would become depressed or suicidal while taking Sanofi-Aventis’ weight loss drug Acomplia, which might have helped keep the drug on the market, U.S. researchers said on Thursday.

See more here:
Gene testing could have saved weight-loss drug
(Reuters)

« Previous Page